$132 Million is the total value of Worth Venture Partners, LLC's 209 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | CAESARS ENTMT CORPnote 5.000%10/0 | $10,322,000 | – | 8,287,000 | +100.0% | 7.81% | – | |
New | NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $8,421,000 | – | 7,086,000 | +100.0% | 6.37% | – | |
New | SQUARE INCnote 0.375% 3/0 | $7,853,000 | – | 3,209,000 | +100.0% | 5.94% | – | |
New | CLEVELAND CLIFFS INCdbcv 1.500% 1/1 | $4,956,000 | – | 4,500,000 | +100.0% | 3.75% | – | |
QCOM | New | QUALCOMM INC | $3,838,000 | – | 67,444 | +100.0% | 2.90% | – |
New | WRIGHT MED GROUP N Vnote 2.250%11/1 | $3,434,000 | – | 2,500,000 | +100.0% | 2.60% | – | |
New | Yahoo INcnote | $2,624,000 | – | 2,288,000 | +100.0% | 1.98% | – | |
New | MEDICINES COput | $1,618,000 | – | 218,200 | +100.0% | 1.22% | – | |
New | INTERCEPT PHARMACEUTICALS INput | $1,191,000 | – | 140,300 | +100.0% | 0.90% | – | |
New | HORIZON PHARMA PLCnote 2.500% 3/1 | $1,148,000 | – | 1,158,000 | +100.0% | 0.87% | – | |
XLNX | New | XILINX INC | $1,106,000 | – | 13,000 | +100.0% | 0.84% | – |
New | IMMUNOMEDICS INCcall | $999,000 | – | 128,100 | +100.0% | 0.76% | – | |
XLY | New | SELECT SECTOR SPDR TRsbi cons discr | $967,000 | – | 9,771 | +100.0% | 0.73% | – |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $886,000 | – | 10,400 | +100.0% | 0.67% | – |
KEM | New | KEMET CORP | $735,000 | – | 42,000 | +100.0% | 0.56% | – |
APPS | New | DIGITAL TURBINE INC | $678,000 | – | 370,579 | +100.0% | 0.51% | – |
PBYI | New | PUMA BIOTECHNOLOGY INC | $565,000 | – | 27,820 | +100.0% | 0.43% | – |
DMAC | New | DIAMEDICA THERAPEUTICS INC | $377,000 | – | 129,863 | +100.0% | 0.28% | – |
New | QUALCOMM INCput | $348,000 | – | 91,900 | +100.0% | 0.26% | – | |
XLP | New | SELECT SECTOR SPDR TRsbi cons stpls | $347,000 | – | 6,863 | +100.0% | 0.26% | – |
QMCO | New | QUANTUM CORP | $336,000 | – | 168,500 | +100.0% | 0.25% | – |
XLC | New | SELECT SECTOR SPDR TR | $221,000 | – | 5,388 | +100.0% | 0.17% | – |
MLND | New | MILLENDO THERAPEUTICS INC | $206,000 | – | 25,951 | +100.0% | 0.16% | – |
New | INSMED INCput | $206,000 | – | 95,500 | +100.0% | 0.16% | – | |
AGX | New | ARGAN INC | $197,000 | – | 5,211 | +100.0% | 0.15% | – |
VVUS | New | VIVUS INCnote 4.500% 5/0 | $111,000 | – | 50,292 | +100.0% | 0.08% | – |
New | CAESARS ENTMT CORPput | $99,000 | – | 73,800 | +100.0% | 0.08% | – | |
New | IMMUNOMEDICS INCput | $88,000 | – | 157,100 | +100.0% | 0.07% | – | |
New | CLEVELAND CLIFFS INCdbcv 1.500% 1/1 | $52,000 | – | 91,800 | +100.0% | 0.04% | – | |
IEC | New | IEC ELECTRS CORP NEW | $48,000 | – | 8,800 | +100.0% | 0.04% | – |
FOMX | New | FOAMIX PHARMACEUTICALS LTD | $48,000 | – | 13,500 | +100.0% | 0.04% | – |
ATEX | New | PDVWIRELESS INC | $42,000 | – | 1,128 | +100.0% | 0.03% | – |
New | WEATHERFORD INTL PLCput | $38,000 | – | 39,500 | +100.0% | 0.03% | – | |
New | KBR INCput | $20,000 | – | 44,100 | +100.0% | 0.02% | – | |
New | CONATUS PHARMACEUTICALS INCcall | $13,000 | – | 40,000 | +100.0% | 0.01% | – | |
APHA | New | APHRIA INC | $12,000 | – | 2,309 | +100.0% | 0.01% | – |
WFTIQ | New | WEATHERFORD INTL PLC | $9,000 | – | 17,000 | +100.0% | 0.01% | – |
PTIE | New | PAIN THERAPEUTICS INC | $6,000 | – | 8,178 | +100.0% | 0.01% | – |
New | PUMA BIOTECHNOLOGY INCcall | $5,000 | – | 20,000 | +100.0% | 0.00% | – | |
New | INTERCEPT PHARMACEUTICALS INcall | $4,000 | – | 700 | +100.0% | 0.00% | – | |
New | INTRA CELLULAR THERAPIES INCcall | $2,000 | – | 101,100 | +100.0% | 0.00% | – | |
New | BIOMARIN PHARMACEUTICAL INCnote 1.500%10/1 | $0 | – | 0 | +100.0% | 0.00% | – | |
New | QUALCOMM INCcall | $0 | – | 100 | +100.0% | 0.00% | – | |
New | PANDORA MEDIA INCput | $0 | – | 300 | +100.0% | 0.00% | – | |
New | SPDR S&P 500 ETF TRput | $0 | – | 13,500 | +100.0% | 0.00% | – | |
New | WEATHERFORD INTL PLCcall | $0 | – | 14,700 | +100.0% | 0.00% | – | |
SPY | New | SPDR S&P 500 ETF TRtr unit | $0 | – | 1 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AIRGAIN ORD | 25 | Q3 2023 | 1.8% |
PIXELWORKS ORD | 23 | Q3 2022 | 1.3% |
SILICOM ORD | 22 | Q3 2023 | 1.8% |
DSP GROUPS INC | 20 | Q3 2021 | 1.4% |
DIGITAL TURBINE ORD | 19 | Q2 2023 | 1.0% |
BK OF AMERICA CORP | 17 | Q3 2023 | 1.1% |
EQUITY COMWLTH REIT ORD | 17 | Q3 2023 | 0.7% |
ISHARES TR | 16 | Q4 2020 | 3.0% |
SCPHARMACEUTICALS ORD | 16 | Q3 2023 | 2.8% |
SELECT SECTOR SPDR TR | 16 | Q4 2020 | 1.3% |
View Worth Venture Partners, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
13F-HR | 2023-11-15 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
13F-HR | 2022-02-14 |
13F-HR | 2021-11-15 |
View Worth Venture Partners, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.